Enhanced Eradication of Mucin-Embedded Bacterial Biofilm by Locally Delivered Antibiotics in Functionalized Microcontainers.

Macromolecular Bioscience
Stine Egebro BirkAnja Boisen

Abstract

Bacterial biofilm-related infections are difficult to eradicate and require repeated treatments with high doses of antibiotics. Thus, there is an urgent need for new treatment strategies that minimize the use of antibiotics while enhancing biofilm eradication. Functionalized reservoir-based microdevices, such as, microcontainers (MCs), offer, high drug loading capacity, mucus embedment, and tuneable drug release. Here, MCs are loaded with the antibiotic ciprofloxacin (CIP), and sealed with a lid consisting of chitosan (CHI) and a mucolytic agent, N-acetylcysteine (NAC). It is found that CHI and NAC work synergistically, showing improved mucoadhesive and mucolytic properties. To better mimic the in vivo habitat of Pseudomonas aeruginosa (P. aeruginosa), the biofilm is grown in a mucin-containing medium on a newly developed centrifugal microfluidic system. The CHI/NAC coated MCs improve eradication of biofilm (88.22 ± 2.89%) compared to CHI-coated MCs (72.68 ± 3.73%) or bolus injection (39.86 ± 13.28%). The findings suggest that MCs are significantly more efficient than a bolus treatment. Furthermore, CHI/NAC functionalized MCs kill most of the biomass already after 5 h (80.75 ± 3.50%), mainly due to a fast drug release. This is ...Continue Reading

References

Apr 1, 1992·Journal of Internal Medicine·F FranzettiM Moroni
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Jun 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Aamer AhmedTejal A Desai
Feb 4, 2003·Nature Reviews. Drug Discovery·David Davies
Jun 7, 2003·Molecular Microbiology·Mikkel KlausenTim Tolker-Nielsen
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cheol-In KangKang-Won Choe
Oct 7, 2003·International Journal of Antimicrobial Agents·Anna MarcheseAnna Maria Schito
Nov 11, 2003·Biomacromolecules·Entsar I RabeaWalter Steurbaut
Dec 20, 2005·Molecular Microbiology·Rebecca M LandryMatthew R Parsek
Dec 19, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Garth A JamesPhilip S Stewart
Dec 22, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Dharmendra Jain, R Banerjee
Feb 27, 2009·Clinical Pharmacology and Therapeutics·N M ElmanM J Cima
Sep 5, 2009·Advances in Applied Microbiology·Andrew J McBain
Dec 22, 2009·Journal of Bacteriology·Jens KlockgetherBurkhard Tümmler
May 4, 2010·Applied and Environmental Microbiology·Michael R BenoitA Matin
May 14, 2010·BMC Microbiology·Tiemei Zhao, Youning Liu
Feb 10, 2012·Lab on a Chip·Jeongyun KimArul Jayaraman
Apr 24, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Line Hagner NielsenAnette Müllertz
Sep 7, 2012·Cold Spring Harbor Perspectives in Medicine·Silvia M KredaMary Callaghan Rose
Oct 3, 2012·Journal of Internal Medicine·U Römling, C Balsalobre
Mar 13, 2013·Nature Reviews. Gastroenterology & Hepatology·Malin E V JohanssonGunnar C Hansson
Apr 27, 2013·Biochimica Et Biophysica Acta·Yuval SamuniMichael Berk
Feb 20, 2014·Advanced Drug Delivery Reviews·Meng-Hua XiongJun Wang
Mar 1, 2014·Biochemistry·Katie J AldredNeil Osheroff
May 7, 2014·Journal of Internal Medicine·U RömlingB Åkerlund
Oct 12, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Zahra MerchantSatyanarayana Somavarapu
Apr 29, 2015·Antimicrobial Agents and Chemotherapy·Janus A J HaagensenKatherine Yang
Apr 2, 2016·International Journal of Pharmaceutics·Line Hagner NielsenAnja Boisen
Jul 28, 2016·Cold Spring Harbor Perspectives in Medicine·David C Hooper, George A Jacoby
Nov 22, 2016·Critical Reviews in Microbiology·Joana AzeredoClaus Sternberg
Dec 21, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Line Hagner NielsenAnja Boisen
Apr 30, 2017·The Journal of Microbiology·Sungil JangJeong-Heon Cha
Sep 21, 2017·Frontiers in Cellular and Infection Microbiology·Jean-Félix SicardJosée Harel
Oct 22, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chiara MazzoniAnja Boisen
Nov 22, 2017·Pharmaceutics·Munawar A MohammedEllen K Wasan
Dec 14, 2017·Scientific Reports·Fabíola CostaM Cristina L Martins

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.